Intellectual Property India Publishes Patent Application for Bispecific Anti-Psma X Anti-Cd28 Antibodies And Uses Thereof

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202648124467 A) filed by Regeneron Pharmaceuticals, Inc. on October 16, 2026, for Bispecific Anti-Psma X Anti-Cd28 Antibodies And Uses Thereof.

Inventors include Murphy, Andrew, J.; Skokos, Dimitris; Waite, Janelle; Ullman, Erica; Hermann, Aynur; Smith, Eric; Haber, Lauric Filed On; and Yancopoulos, George, D..

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present invention provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds human CD28, and a second antigen-binding molecule that specifically binds human PSMA. In certain embodiments, ...